Skip to main content
logo
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.760
-0.010 (-0.27%)
At close: Aug 28, 2026, 4:00 PM EDT
3.770
+0.010 (0.27%)
After-hours: Aug 28, 2026, 4:27 PM EDT

Neuphoria Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
2013----
Market Cap Growth
5.77%-----
Enterprise Value
1-4----
Last Close Price
3.767.10----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
-1531.700.85----
PB Ratio
0.690.70----
P/TBV Ratio
1.252.40----
P/FCF Ratio
-172.83----
P/OCF Ratio
-172.83----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.000.010.020.020.010.02
Debt / FCF Ratio
-1.93----
Net Debt / Equity Ratio
-0.66-0.74-0.70-0.53-0.58-0.58
Net Debt / EBITDA Ratio
1.3984.560.720.561.972.96
Net Debt / FCF Ratio
1.13-182.080.840.801.513.67
Asset Turnover
-0.56--0.100.02
Quick Ratio
13.913.373.334.5812.0212.55
Current Ratio
14.313.563.454.8712.4613.10
Return on Equity (ROE)
-62.90%-2.03%-78.44%-71.40%-41.64%-28.86%
Return on Assets (ROA)
-27.97%-1.84%-39.58%-37.41%-18.40%-14.48%
Return on Capital Employed (ROCE)
-44.00%-3.40%-74.70%-83.50%-28.40%-19.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-85.78%-2.77%----
FCF Yield
-84.40%0.58%----
Buyback Yield / Dilution
-161.08%-95.01%99.94%-8.53%-73.52%-43.14%
SEC Filings: 10-K · 10-Q